Show Notes
Vicki Munro is a very experienced Health Economist and Senior Associate at Pym’s Consultancy. We discuss the role of Health Economics in bringing a new product to market and the vital part Health Economics plays in NICE Approval. Thought passing regulatory hurdles was enough? Think again, what does your Cost Per QALY look like?
More from MedTech For Beginners
In this episode of MedTech for Beginners, Kate Pym is joined by Bryan Lister, regulatory consultant and founder of InViva Healthcare Management, for a practical conversation about medical device regulation and why founders should think about it much earlier than they often do. Bryan works with universities, SMEs, and first-time entrepreneurs to help them navigate the regulatory pathway and bring healthcare products to market. Together, they discuss what happens when regulation is treated as ...
In this episode of MedTech for Beginners, Kate Pym speaks with Dr Tom Adler, former GP and co-founder of Bide, about the journey from a clinical problem to a real product used to help reduce the risk of nighttime falls. Tom shares how years of caring for patients in rural general practice, along with his personal experience of seeing his mother live with Alzheimer’s disease and suffer a series of falls, led him to focus on fall prevention rather than fall detection. They discuss the origina...
Welcome to the first episode of MedTech for Beginners. In this episode, Kate Pym is joined by Dr Jyoti Baharani, Consultant Nephrologist at University Hospitals Birmingham, for a thoughtful conversation about patient communication, digital education, leadership, and mentorship in healthcare. They discuss why written information does not work for every patient, how digital and video-based education can make healthcare information more accessible, and the importance of designing resources aro...
In this episode, Kate wraps up the end of this mini-series with Kerry Lummus. They discuss insights gained from the series so far and leave listeners with key takeaways of what to consider when bringing new products into the healthcare market.
As a change from the norm this episode with Gail Jackson, CEO of Solving Kids’ Cancer, brings a challenge to our listeners. As innovators and fresh thinkers, what ideas do you have to overcome research challenges in childhood cancer treatments? Did you know that in 2022 only £80,000 was paid by the central government for neuroblastoma research? How can we find better, less toxic treatments for children when funding and regulation work against us? Calling all innovators, listen to th...